acut
respiratori
diseas
compris
overal
infecti
diseas
occurr
develop
countri
caus
virus
influenza
viru
iv
recogn
seriou
public
health
concern
hospit
death
annual
unit
state
alon
date
convent
commerci
antivir
agent
iv
develop
control
iv
pandem
block
two
differ
target
matrix
protein
ion
channel
neuraminidas
na
transport
h
ion
across
transmembran
block
ion
channel
inhibitor
result
incomplet
viral
uncoat
prevent
viral
replic
na
inhibitor
interrupt
hydrolysi
termin
sialic
acid
residu
new
iv
thu
prevent
releas
virus
infect
host
cell
promot
iv
infect
interrupt
inhibitor
howev
us
center
diseas
control
cdc
announc
iv
strain
present
resist
ion
channel
inhibitor
includ
amantadin
rimantadin
furthermor
recent
influenza
strain
includ
respons
pandem
outbreak
show
enorm
high
resist
commerci
na
inhibitor
tamiflu
oseltamivir
mutat
viral
surfac
protein
trigger
increment
iv
resist
convent
drug
treatment
transform
drug
bind
site
protein
henc
increas
viral
infect
mortal
hemagglutinin
ha
one
viral
surfac
protein
deepli
involv
membran
fusion
host
cell
investig
anoth
potenti
effect
antivir
strategi
fusion
process
disulfid
bond
link
two
differ
part
ha
cleav
unfold
ha
molecul
fusion
peptid
hidden
within
caus
membran
fusion
spread
viral
rna
host
cell
disulfid
bond
crucial
role
membran
fusion
process
previous
describ
thu
focus
ha
disulfid
bond
antivir
target
herein
meanwhil
inorgan
metal
gold
silver
investig
abil
neutral
ha
activ
cleav
ha
disulfid
bond
use
strong
affin
gold
silver
especi
report
silverthiol
interact
ha
disulfid
bond
silver
nanoparticl
agnp
could
inhibit
iv
infect
cleav
disulfid
bond
therefor
variou
modif
nobl
metal
nanoparticl
test
mitig
viral
infect
ie
tannic
acidmodifi
silver
nanoparticl
silver
nanoparticlechitosan
composit
curcuminmodifi
silver
nanoparticl
pvpcoat
silver
nanoparticl
multival
gold
nanoparticl
gallic
acidfunction
gold
nanoparticl
nobl
metalbas
nanoparticl
suppress
viral
infect
block
viral
entri
host
cell
improv
antivir
treatment
agent
use
metal
nanoparticl
introduc
porou
gold
nanoparticl
pognp
cleav
disulfid
bond
pognp
permit
facil
fabric
process
requir
addit
heat
surfact
agbas
nanoparticl
modifi
cap
agent
stabil
vitro
condit
reduc
cytotox
addit
pognp
possess
extens
surfac
area
due
uniqu
nanobundl
structur
moreov
pognp
expect
high
affin
disulfid
bond
due
golddisulfid
bond
format
extens
surfac
area
effect
inactiv
iv
cleav
disulfid
bond
block
membran
fusion
viral
entri
host
cell
present
studi
influenza
viru
iav
treat
pognp
show
pognp
inactiv
viru
scheme
visual
inactiv
abil
amount
postinfect
intracellular
viral
rna
measur
nanoparticl
treatment
addit
variou
iv
strain
includ
analyz
confirm
inhibit
efficaci
pognp
regardless
iav
mutat
contrast
convent
gold
nanoparticl
synthesi
pognp
synthes
use
surfactantfre
emuls
method
ion
anilinium
ion
form
paniau
complex
nanoparticl
reduc
ion
oxid
anilinium
ion
pani
redox
reaction
fabric
paniau
complex
nanoparticl
pani
select
etch
nmp
paniau
nanocomplex
shape
mesopor
gold
structur
nonpor
sgnp
synthes
via
seedmedi
growth
method
compar
whether
nanoparticl
morpholog
could
affect
inactiv
viru
agnp
also
prepar
antivir
control
group
agnp
wide
studi
antivir
properti
morpholog
synthes
nanoparticl
observ
tem
averag
size
determin
dynam
light
scatter
dl
analysi
tem
imag
synthes
pognp
exhibit
rough
surfac
nmsize
nanospher
bundl
compos
nm
size
spheric
structur
fig
wherea
sgnp
agnp
exhibit
narrow
monodispers
spheric
structur
smooth
surfac
fig
c
addit
file
figur
cumul
size
pognp
agnp
sgnp
nm
nm
nm
respect
fig
zeta
potenti
formul
pognp
rather
neutral
charg
mv
compar
sgnp
mv
agnp
mv
moreov
biocompat
synthes
nanoparticl
evalu
mdck
cell
viabil
assay
mdck
cell
plate
expos
variou
nanoparticl
concentr
cell
viabil
measur
assay
optic
densiti
measur
nm
measur
cell
viabil
nanoparticl
treatment
greater
except
mgml
pognp
mgml
agnp
observ
cell
viabil
result
nanoparticl
cell
viabil
assay
impli
infect
nanoparticletr
virus
could
evalu
mdck
cytotox
assay
nanoparticl
exhibit
good
biocompat
mdck
cell
addit
file
figur
interact
prepar
nanoparticl
iav
ha
evalu
hypothes
inactiv
iav
induc
cleav
disulfid
bond
requir
viral
membran
fusion
host
cell
tem
analysi
first
conduct
simpl
confirm
interact
viru
nanoparticl
iav
suspens
incub
mgml
nanoparticl
min
mixtur
prepar
tem
analysi
howev
interact
difficult
observ
tem
imag
larger
np
pognp
sgnp
hand
agnp
agglomer
viral
surfac
expect
sinc
small
size
agnp
facilit
migrat
fig
anoth
techniqu
consid
prove
affin
ha
larger
sgnp
isol
iav
requir
ultracentrifug
gradient
centrifug
centrifug
sampl
min
monitor
whether
precipit
nanoparticl
assum
nanoparticletr
viru
would
precipit
nanoparticl
contrast
viru
sampl
alon
definit
realtim
cycl
quantif
cq
valu
pognptreat
viru
redispers
precipit
solut
much
lower
supernat
indic
viru
could
interact
pognp
fig
addit
pognp
attract
viru
sgnp
lower
concentr
accord
realtim
cq
valu
precipit
sampl
indic
pognp
much
higher
affin
ha
compar
sgnp
differ
attract
result
surfac
structur
foamshap
porou
outer
surfac
pognp
creat
surfac
area
interact
ha
sgnp
surfac
observ
antivir
effect
nanoparticl
viru
expos
nanoparticl
suspens
min
min
prior
infect
mdck
cell
antivir
effect
nanoparticl
determin
cytotox
assay
observ
optic
densiti
treat
cell
nm
compar
nanoparticl
pognp
show
much
higher
antivir
activ
viru
wherea
agnp
show
minor
antivir
activ
mgml
agnp
mgml
pognp
success
inactiv
viru
exposur
min
contrast
sgnp
antivir
effect
regardless
concentr
exposur
time
fig
compar
pognp
sgnp
differ
nanoparticl
antivir
activ
result
differ
specif
surfac
area
despit
similar
diamet
nanofram
pognp
behav
singl
reactant
disulfid
bond
could
interact
ha
agnp
abl
agglomer
viral
ha
extens
specif
surfac
area
interact
compar
sgnp
due
small
size
howev
pognp
show
higher
inactiv
viru
mgml
pognp
superior
viru
inactiv
abil
compar
agnp
sgnp
due
stabil
salin
condit
high
affin
ha
antivir
effect
agnp
restrict
agnp
aggreg
cultur
media
higher
concentr
treat
concentr
lower
mgml
due
toxic
concern
observ
lower
attract
sgnp
viral
ha
bind
effici
test
centrifug
sgnp
exhibit
lower
antivir
activ
expect
inde
inactiv
viru
sgnp
much
lower
pognp
although
sgnp
also
exhibit
affin
ha
higher
concentr
result
endors
fact
inactiv
viru
caus
cleavag
disulfid
bond
ensu
influenc
metal
nanoparticl
rel
flat
surfac
sgnp
made
contact
disulfid
bridg
difficult
contrast
pognp
rough
surfac
confirm
inactiv
pognp
regardless
genet
mutat
iav
strain
treat
pognp
fig
addit
file
figur
accord
phylogen
tree
iav
select
viru
strain
low
sequenc
similar
consid
repres
gener
viral
treatment
mintreat
sampl
mgml
pognp
show
cell
viabil
mgml
pognp
concentr
treat
viru
slightli
inactiv
compar
nontreat
viru
min
treatment
antivir
effect
treatment
mgml
pognp
increas
respect
mdck
cell
surviv
infect
treat
mgml
pognp
min
minorli
affect
mgml
pognp
still
exhibit
higher
cell
viabil
control
group
pognp
display
antivir
activ
variou
viru
strain
import
onthespot
preprocess
iav
analysi
could
conclud
mgml
pognp
could
attenu
infect
multipl
iav
strain
infer
inactiv
mechan
viru
cleavag
disulfid
bond
high
affin
disulfidegold
interact
abund
presenc
disulfid
bond
ha
would
expedit
inhibit
pognp
viral
inhibit
mechan
pognp
identifi
quantit
analysi
intracellular
viral
rna
mdck
cell
infect
nanoparticletr
virus
fig
mdck
cell
infect
pognptreat
viru
h
cell
lyse
qiagen
rneasi
mini
kit
follow
calcul
valu
standard
eid
curv
addit
file
figur
pognptreat
viru
show
lower
intracellular
viral
rna
level
indic
amount
iav
endosom
mdck
cell
clearli
reduc
nanoparticletr
sampl
also
amount
intracellular
viral
rna
clearli
influenc
exposur
time
gene
content
level
viral
rna
host
cell
higher
virus
treat
min
compar
min
intracellular
viral
rna
quantif
data
correspond
well
mdck
cell
viabil
test
result
reveal
antivir
activ
pognp
affect
time
concentr
especi
mgml
pognp
effect
exposur
min
furthermor
result
also
confirm
pognp
block
viral
infect
inhibit
viral
entri
determin
viral
infect
suppress
obstruct
viral
attach
therefor
experi
prove
disulfid
bond
ha
import
role
viral
infect
support
hypothesi
acid
dtnb
reduct
assay
ellman
assay
propos
quantifi
reduc
disulfid
bond
viru
hemagglutinin
contact
mgml
pognp
sgnp
agnp
fig
higher
sulfhydryl
group
concentr
viru
mean
reduct
disulfid
bond
occur
ellman
assay
consid
valid
method
prove
relationship
viral
disulfid
bond
reduct
attenu
infect
describ
fig
absorb
nm
influenza
viru
expos
mgml
pognp
show
higher
sgnp
agnp
counterpart
concentr
indic
pognp
higher
affin
disulfid
bond
ha
despit
size
pognp
slightli
larger
sgnp
pognp
higher
rel
surfac
area
made
big
differ
disulfid
bond
reduct
agnp
still
display
reduct
reaction
bond
ha
tcep
chosen
posit
control
group
disulfid
bond
reduc
agent
sinc
tcep
structur
disulfid
bond
reduc
bond
ha
thu
littl
effect
dtnb
reduct
react
disulfid
bond
ha
moreov
result
assay
reveal
tceptreat
iav
lost
infect
similar
pognptreat
virus
sampl
treat
mm
tcep
exhibit
nearli
cell
viabil
much
higher
viabil
virusinfect
mdck
cell
addit
file
figur
hand
tceptreat
sampl
display
lower
cell
viabil
compar
tceptreat
sampl
cytotox
tcep
result
suggest
cleavag
disulfid
bond
membran
fusion
reduc
viral
infect
toward
mdck
cell
likewis
viral
infect
pognpreact
influenza
viru
suppress
level
similar
tcep
interact
one
deriv
pognp
also
cleav
disulfid
bond
ha
tcep
demonstr
antivir
activ
pognp
comparison
nonpor
gold
silver
nanoparticl
studi
nanoparticl
morpholog
interact
iav
observ
tem
analysi
interact
pognp
ha
proven
coprecipit
centrifug
precipit
pognptreat
iav
show
lower
realtim
cq
valu
indic
virus
precipit
nanoparticl
free
supernat
furthermor
pognp
show
effect
inhibit
viral
infect
compar
nonpor
sgnp
agnp
extens
surfac
area
suggest
viral
inhibit
mechan
due
block
viral
attach
associ
membran
fusion
ensu
cleavag
disulfid
bond
ha
result
indic
disulfid
bond
ha
could
effect
antivir
target
present
possibl
develop
antivir
vaccin
variou
iv
strain
likewis
suggest
pognp
could
appli
envelop
virus
consider
spike
protein
surfac
human
immunodefici
viru
coronaviru
cleav
disulfid
bond
spike
protein
addit
pognp
numer
electromagnet
hot
spot
compar
nonpor
gold
silver
nanoparticl
applic
surfac
enhanc
raman
spectroscopi
ser
consid
futur
analysi
find
studi
impli
facil
detect
iav
achiev
develop
pognp
multiplatform
detect
inactiv
viru
gold
iii
chlorid
trihydr
silver
nitrat
tannic
acid
sodium
citrat
hydroquinon
polyvinylpyrrolidon
pvp
phosphotungst
acid
hydrat
pta
lcystein
monosodium
phosphat
disodium
phosphat
anilin
purchas
sigmaaldrich
st
loui
usa
ethanol
nmp
obtain
duksan
pure
chemic
co
ltd
ansan
south
korea
dulbecco
modifi
eagl
medium
dmem
dulbecco
phosphat
buffer
salin
dpb
ph
fetal
bovin
serum
fb
purchas
gibco
laboratori
gaithersburg
usa
ellman
reagent
acid
dtnb
purchas
thermo
scientif
waltham
usa
ezcytox
cell
viabil
assay
kit
purchas
daeil
lab
servic
seoul
korea
mini
kit
viral
rna
mini
kit
purchas
qiagen
hilden
germani
awild
bird
prepar
pognp
prepar
follow
surfactantfre
emuls
method
anilin
monom
ml
mmol
dispers
ml
deioniz
water
ml
gold
iii
chlorid
solut
ad
construct
polyanilin
pani
au
hybrid
nanoparticl
emulsif
min
ultrason
produc
paniau
nanoparticl
wash
centrifug
pani
remov
paniau
composit
dissolv
composit
nmp
final
purifi
pognp
redispers
dpb
agnp
synthes
follow
citrat
reduct
method
tannic
acid
mg
mmol
sodium
citrat
mg
mmol
dissolv
ml
deioniz
water
solut
heat
vigor
stir
ml
silver
nitrat
solut
mm
quickli
inject
react
h
nonpor
sgnp
obtain
follow
seedmedi
growth
method
first
gold
nanoparticl
gnp
seed
synthes
use
citrat
reduct
method
briefli
ml
sodium
citrat
solut
mm
heat
vigor
stir
thereaft
ml
gold
iii
chlorid
solut
inject
sodium
citrat
solut
min
winecolor
gnp
seed
solut
obtain
gold
iii
chlorid
solut
mm
ad
gnp
seed
solut
give
final
volum
ml
subsequ
sodium
citrat
solut
mm
inject
seed
solut
mixtur
follow
addit
hydroquinon
solut
mm
mixtur
kept
room
temperatur
rt
h
pvp
solut
ad
prevent
aggreg
nanoparticl
follow
centrifug
rpm
min
size
distribut
zeta
potenti
nanoparticl
collect
otsuka
electron
co
ltd
osaka
concentr
particl
analyz
inductivelycoupl
plasma
optic
emiss
spectromet
icpo
perkin
elmer
waltham
aliquot
viru
suspens
expos
mgml
mgml
nanoparticl
pognp
sgnp
solut
incub
rt
h
subsequ
incub
sampl
centrifug
rpm
min
separ
virusbound
nanoparticl
supernat
solut
supernat
transfer
test
tube
precipit
dispers
dpb
thereaft
realtim
rtpcr
analysi
conduct
prepar
solut
determin
bind
effici
nanoparticl
watersolubl
tetrazolium
assay
perform
determin
cytotox
nanoparticletr
iav
mdck
cell
use
ezcytox
cell
viabil
assay
kit
daeil
lab
servic
twentyfour
hour
prior
infect
experi
madindarbi
canin
kidney
mdck
cell
seed
plate
fetal
bovin
serum
fb
contain
dmem
order
evalu
antivir
activ
nanoparticl
variou
nanoparticl
concentr
mgml
mgml
pognp
sgnp
agnp
twofold
serial
dilut
aliquot
iav
prepar
nanoparticl
solut
ad
viru
aliquot
final
nanoparticl
concentr
mgml
mgml
sampl
incub
rt
min
min
vortex
mix
everi
min
meantim
mdck
cell
wash
pb
aliquot
nanoparticletr
iav
sampl
ad
well
incub
addit
h
nanoparticletr
iav
remov
cell
rins
pb
incub
addit
h
fresh
dmem
determin
cell
viabil
ezcytox
ad
incub
cell
optic
densiti
od
nm
measur
h
use
spectramax
micropl
reader
molecular
devic
san
jose
usa
intracellular
viral
rna
quantif
h
mdck
cell
incub
period
follow
mini
kit
protocol
qiagen
prepar
sampl
realtim
rtpcr
analysi
nanoparticl
viru
suspens
mixtur
previous
describ
cytotox
assay
part
incub
rt
min
transfer
pipett
carbonco
copper
tem
grid
mesh
min
rt
liquid
blot
filter
paper
droplet
wt
pta
solut
load
onto
grid
neg
stain
excess
pta
solut
blot
filter
paper
follow
wash
droplet
deioniz
water
grid
dri
h
prior
analysi
tem
imag
obtain
transmiss
electron
microscop
jeol
ltd
tokyo
japan
viru
serial
dilut
tenfold
viral
genom
rna
dilut
extract
use
viral
rna
mini
kit
qiagen
accord
manufactur
instruct
realtim
revers
transcriptionpolymeras
chain
reaction
rtpcr
employ
quantifi
viral
load
sampl
use
quantitect
probe
rtpcr
kit
qiagen
lightcycl
system
roch
basel
switzerland
final
reaction
volum
contain
matrix
genespecif
primer
forward
gaccratcctgtcacctctgac
revers
agggc
attytggacaaakc
gtcta
specif
probe
thermal
cycl
condit
revers
transcript
min
initi
denatur
min
follow
cycl
accord
manufactur
protocol
roch
primer
target
region
gene
highli
conserv
across
iav
strain
formul
cdc
biosearch
technolog
inc
http
standard
curv
gener
eid
valu
copi
number
amount
viral
rna
nanoparticletr
sampl
calcul
standard
curv
gener
realtim
rtpcr
data
use
canin
viru
addit
file
figur
mm
dtnb
ethanol
solut
sodium
phosphat
buffer
ph
prepar
mgml
pognp
sgnp
agnp
aliquot
mix
viru
left
min
rt
mm
dtnb
solut
set
neg
control
signal
viru
suspens
react
mm
tcep
min
prepar
posit
control
subsequ
mm
dtnb
solut
ad
mixtur
centrifug
reactant
follow
remov
nanoparticl
mixtur
next
absorb
nm
observ
use
spectramax
micropl
reader
molecular
devic
san
jose
usa
